Regulatory News
Friday, July 15, 2016
Cancer patient in Ziopharm drug trial dies after starting treatment
July 15 (Reuters) - A brain cancer patient enrolled in
Ziopharm Oncology Inc's trial has suffered a fatal
cranial bleed a fortnight after starting treatment with the gene
therapy developer's lead...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment